title: New therapies against HCV: expected risks and challenges associated with their use in the liver transplant setting.
authors.affiliation: Centenary Research Institute, A.W. Morrow Gastroenterology and Liver Center, Australian National Liver Transplant Unit, Royal Prince Alfred Hospital University of Sydney, Sydney, Australia. g.mccaughan@centenary.usyd.edu.au
authors.forename: Geoffrey W
authors.initials: GW
authors.lastname: McCaughan
mesh_terms: D000998:Antiviral Agents / Q000009:adverse effects / Q000627:therapeutic use*; D006526:Hepatitis C / Q000188:drug therapy* / Q000821:virology; D006801:Humans; D016031:Liver Transplantation; D012306:Risk; D014184:Transplantation, Homologous; D017361:Viral Nonstructural Proteins / Q000037:antagonists & inhibitors; D012324:RNA-Dependent RNA Polymerase
chemical_list: D000998:Antiviral Agents; D017361:Viral Nonstructural Proteins; C087036:NS-5 protein, hepatitis C virus; D012324:RNA-Dependent RNA Polymerase